GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Biopharmaceuticals Co Ltd (XKRX:326030) » Definitions » Securities & Investments

SK Biopharmaceuticals Co (XKRX:326030) Securities & Investments


View and export this data going back to 2020. Start your Free Trial

What is SK Biopharmaceuticals Co Securities & Investments?

Securities & Investments only applies to banks.


SK Biopharmaceuticals Co (XKRX:326030) Business Description

Traded in Other Exchanges
N/A
Address
221, Pangyoyeok-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494
SK Biopharmaceuticals Co Ltd is a pharmaceutical company engaged in research and development of new drugs for treatment of central nervous system (CNS) disorders. The company is also researching for the development of drugs to treat brain tumors, including metastatic tumors. It has a Bio Science Research Institute in Pangyo Techno Valley in Gyeonggi Province. Its drugs in pipeline include Cenobamate, Solriamfetol, Carisbamate, Relenopride, SKL13865, SKL20540, SKL-PSY, and SKL24741.